enGene Therapeutics Inc. (ENGN) SEC filings
ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
$2.41+0.13 (+5.70%)
Close on Nov 13, 2026Market cap $161.51MP/E –Yield 0.00%
SEC filings
40 of enGene Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Nov 11, 2026 | Nov 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 17, 2026 | Jul 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2026 | Jul 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 10, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 9, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2026 | Apr 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Oct 31, 2025 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 21, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 21, 2026 | SEC EDGAR |
| Annual report | 10-K | Oct 31, 2025 | Dec 22, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 22, 2025 | Dec 22, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 11, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2025 | Oct 2, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Sep 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2025 | Sep 11, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2025 | Sep 11, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2025 | Sep 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2025 | Jul 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2025 | Jun 4, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2025 | May 9, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2025 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 10, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Oct 31, 2024 | Feb 20, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 20, 2024 | Dec 20, 2024 | SEC EDGAR |
| Annual report | 10-K | Oct 31, 2024 | Dec 19, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2024 | Dec 19, 2024 | SEC EDGAR |
See a number that looks wrong?